Bengaluru-based Strand Life Sciences, a Reliance Industries subsidiary, has partnered with Agilent, Celemics, and SOPHiA ...

Strand Life Sciences, a subsidiary of Reliance Industries, has introduced CancerSpot, a blood-based test for early cancer ...

Genomic testing involves analysing or sequencing a person’s DNA, to identify genetic changes that can help diagnose or screen ...

Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling technology for early detection of multiple cancers. The test aims to address the growing cancer burden in ...

Called CancerSpot, the test uses the latest globally accepted methylation profiling technology to identify cancer tumour DNA ...

These advancements are customised to meet the unique requirements of the Indian population and provide unmatched precision, economy, and efficiency, according to a release by the company. Advisory ...

Strand Life Sciences, a subsidiary of Reliance Industries Limited, is a genomics-based research and diagnostics company that combines a long track record in bioinformatics with cutting-edge laboratory ...

Strand Life Sciences introduces CancerSpot, a blood-based test using methylation profiling for early detection of multiple ...

Strand Life Sciences is a company based in Bengaluru, Karnataka, India, specialising in the healthtech sector. Founded in 2000, it now employs 533 individuals. The company was established by ...

Strand Life Sciences subsidiary of Reliance Life Sciences launches blood test for early detection of multiple cancers: Our Bureau, Bengaluru Monday, December 2, 2024, 14:40 Hrs [I ...